Nutrigenomics Market: Market Size & Forecast 2026

Nutrigenomics sits at the intersection of nutritional science and genomics, translating genetic data into tailored dietary guidance, functional foods, and supplements. The market encompasses genetic testing kits, personalized nutrition platforms, and associated software and services sold through clinical, direct-to-consumer, and wellness channels. Forecasts from independent analysts cluster around $0.8 billion to $1.0 billion for 2025, with most projecting double-digit annual growth well into the next decade. No government statistical agency publishes official figures for this niche sector, so all size estimates come from private market research providers.

• •2025 market size estimated at roughly $0.94 billion across major industry analyses
• •Compound annual growth rate consensus is approximately 16.3%, with individual forecasts ranging from 14.2% to 17.6%
• •Long-term projections see the market reaching $2.8 billion to $3.9 billion by the early-to-mid 2030s

The steep decline in the cost of whole-genome and SNP genotyping has moved nutrigenomic testing from a research setting into mainstream consumer and clinical use, making personalized nutrition economically viable at scale. Rising prevalence of chronic lifestyle diseases such as obesity, diabetes, and cardiovascular conditions is pushing both consumers and healthcare providers toward preventive, gene-informed dietary interventions. Growing digital health infrastructure, including AI-driven diet recommendation engines and integration with wearables, further accelerates adoption.

• •DNA sequencing costs have fallen more than 99% since the mid-2000s, enabling affordable consumer testing
• •Chronic disease burden and preventive healthcare trends are expanding the addressable population
• •Integration with digital health platforms and telehealth is improving scalability and consumer engagement

The market is typically segmented by product type (genetic testing kits, personalized nutrition services, and functional foods/supplements), application (obesity, cardiovascular health, diabetes, cancer, and general wellness), and end user (clinical, research, and direct-to-consumer). North America currently leads revenue share, supported by high consumer awareness, established genetic testing infrastructure, and a strong direct-to-consumer wellness ecosystem. Europe follows, driven by public research initiatives and growing clinical adoption, while Asia-Pacific is the fastest-growing region as disposable incomes rise and precision medicine initiatives expand in China, Japan, India, and South Korea.

• •Genetic testing kits represent the largest product segment by current revenue
• •North America holds the leading regional share; Asia-Pacific is forecast as the fastest-growing region through 2030
• •Wellness and obesity-related applications account for the largest application sub-segments

What are the recent trends and outlook?

Key forward-looking trends include the convergence of nutrigenomics with microbiome analysis and continuous wearable biomarker data to deliver more dynamic personalization. Regulatory frameworks, particularly around direct-to-consumer genetic health claims, are tightening in the U.S., EU, and parts of Asia, which is pushing providers toward more clinically validated offerings and healthcare provider channels. Over the forecast horizon, the market is expected to shift from one-off genetic tests toward subscription-based, continuously updated personalized nutrition services integrated with broader preventive care.

• •Multi-omics integration (genomics plus microbiome, metabolomics, and wearable data) is the leading innovation frontier
• •Regulatory scrutiny on health-related genetic claims is increasing, favoring clinically validated providers
• •Subscription-based personalized nutrition models are expected to outpace one-time test sales through 2030